Interestingly, p21 has been shown to be overexpressed in a variety of human cancers including prostate, cervical, breast and squamous cell carcinomas and, in many cases, p21 upregulation correlates positively with tumor grade, invasiveness and aggressiveness and is a poor prognostic indicator [37]. This evidence concerns the gene CDKN1A and cancer.